Valuation: BioGaia AB

Market Cap 11.72B 1.24B 1.06B 992M 908M 1.7B 118B 1.73B 4.57B 59.51B 4.65B 4.55B 197B P/E 2026 *
30.3x
P/E 2027 * 24.7x
Enterprise Value 11.06B 1.17B 1B 936M 857M 1.61B 112B 1.63B 4.31B 56.13B 4.38B 4.29B 186B EV / Sales 2026 *
6.62x
EV / Sales 2027 * 5.9x
Free-Float
80.82%
Yield 2026 *
2.55%
Yield 2027 * 2.76%
1 day-0.26%
1 week+0.61%
Current month+0.26%
1 month+0.26%
3 months-11.86%
6 months+8.12%
Current year+9.13%
1 week 113.8
Extreme 113.8
117.8
1 month 110.3
Extreme 110.3
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 29/09/2023
Director of Finance/CFO 59 04/11/2019
Chief Operating Officer 49 31/12/2020
Director TitleAgeSince
Chairman 77 31/12/2002
Chairman 76 24/04/2018
Director/Board Member 46 31/12/2014
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+0.61%+17.31%+14.75% 1.24B
+0.90%+3.80%+41.49%-0.81% 83.28B
+8.86%+129.20%+435.14%+25.70% 57.94B
+0.48%+25.64%-21.85%-35.91% 57.77B
-1.46%+0.19%-2.06%+32.21% 51.75B
+0.18%+3.11%+10.50%+172.58% 49.35B
+1.13%+3.31%+55.61%-18.13% 32.03B
+0.46%+6.37%+50.29%+97.70% 25.91B
-2.83%+4.35%-0.45%+187.16% 22.74B
-1.09%-0.74%+56.58%+109.02% 16.87B
Average +0.64%+18.68%+64.26%+58.43% 39.89B
Weighted average by Cap. +1.29%+24.91%+79.89%+44.11%

Financials

2026 *2027 *
Net sales 1.67B 176M 151M 141M 129M 243M 16.87B 246M 651M 8.47B 662M 648M 28.03B 1.88B 198M 170M 159M 145M 273M 18.96B 276M 732M 9.52B 744M 728M 31.5B
Net income 387M 40.87M 35.01M 32.76M 29.98M 56.27M 3.91B 57.02M 151M 1.96B 153M 150M 6.5B 474M 50.06M 42.88M 40.12M 36.72M 68.92M 4.79B 69.83M 185M 2.41B 188M 184M 7.96B
Net Debt -667M -70.44M -60.34M -56.46M -51.68M -96.99M -6.74B -98.27M -260M -3.39B -264M -259M -11.2B -646M -68.17M -58.39M -54.64M -50.01M -93.86M -6.52B -95.1M -252M -3.28B -256M -250M -10.84B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
24/08/26 SEK 115.90 0.00% 6,077
21/08/26 SEK 115.90 +1.05% 138,106
20/08/26 SEK 114.70 -0.26% 149,864
19/08/26 SEK 115.00 -0.52% 187,690
18/08/26 SEK 115.60 +0.35% 110,599
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
115.90SEK
Average target price
152.50SEK
Spread / Average Target
+31.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock